UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
or

Sarepta Therapeutics (SRPT)

Sarepta Therapeutics (SRPT)
107.50 x 2 109.40 x 1
Post-market by (Cboe BZX)
109.46 -0.35 (-0.32%) 02/13/25 [NASDAQ]
107.50 x 2 109.40 x 1
Post-market 109.45 -0.01 (-0.01%) 16:15 ET
Quote Overview for Thu, Feb 13th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
107.74
Day High
110.11
Open 109.40
Previous Close 109.81 109.81
Volume 712,600 712,600
Avg Vol 809,790 809,790
Stochastic %K 9.78% 9.78%
Weighted Alpha -27.83 -27.83
5-Day Change -2.65 (-2.36%) -2.65 (-2.36%)
52-Week Range 102.15 - 173.25 102.15 - 173.25
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,489,050
  • Shares Outstanding, K 95,520
  • Annual Sales, $ 1,243 M
  • Annual Income, $ -535,980 K
  • EBIT $ 84 M
  • EBITDA $ 82 M
  • 60-Month Beta 0.75
  • Price/Sales 6.74
  • Price/Cash Flow N/A
  • Price/Book 8.57

Options Overview Details

View History
  • Implied Volatility 50.79% ( +2.41%)
  • Historical Volatility 32.81%
  • IV Percentile 59%
  • IV Rank 16.15%
  • IV High 147.45% on 05/29/24
  • IV Low 32.18% on 01/22/25
  • Put/Call Vol Ratio 1.72
  • Today's Volume 443
  • Volume Avg (30-Day) 846
  • Put/Call OI Ratio 0.59
  • Today's Open Interest 29,312
  • Open Int (30-Day) 31,182

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 1.87
  • Number of Estimates 9
  • High Estimate 2.26
  • Low Estimate 1.24
  • Prior Year 0.47
  • Growth Rate Est. (year over year) +297.87%

Price Performance

See More
Period Period Low Period High Performance
1-Month
107.74 +1.60%
on 02/13/25
Period Open: 118.43
123.51 -11.38%
on 01/14/25
-8.97 (-7.57%)
since 01/13/25
3-Month
102.15 +7.15%
on 11/18/24
Period Open: 112.48
138.81 -21.14%
on 11/29/24
-3.02 (-2.68%)
since 11/13/24
52-Week
102.15 +7.15%
on 11/18/24
Period Open: 124.19
173.25 -36.82%
on 06/21/24
-14.73 (-11.86%)
since 02/13/24

Most Recent Stories

More News
2 Growth Stocks to Buy Hand Over Fist in February

Not all growth stocks worth buying these days focus on the artificial intelligence field. There are many exciting ones in other industries -- even in healthcare, a sector some investors might consider...

SRPT : 109.46 (-0.32%)
LLY : 871.86 (-0.13%)
Insider Sale: Director at $SRPT (SRPT) Sells 10,500 Shares

Hans Lennart Rudolf Wigzell, a director at $SRPT ($SRPT), sold 10,500 shares of the company on 12-12-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 31.5%...

SRPT : 109.46 (-0.32%)
Arrowhead, Sarepta Stocks Rise Despite Price-Target Cuts Post $1B Licensing Deal: Retail Buzz Strong

Piper reduced Sarepta’s price target to $182 from $200, highlighting the partnership’s near-term financial impact.

ARWR : 19.11 (+2.91%)
SRPT : 109.46 (-0.32%)
Arrowhead Pharma Stock Soars Pre-Market On $825M Sarepta Licensing Deal: Retail Activity Hits Year-High

The global licensing deal includes $500 million in cash and $325 million in equity, at a 35% premium upon closing.

ARWR : 19.11 (+2.91%)
SRPT : 109.46 (-0.32%)
IJH : 63.94 (+0.93%)
VTI : 301.88 (+1.04%)
Sarepta Therapeutics (SRPT) Q3 2024 Earnings Call Transcript

SRPT earnings call for the period ending September 30, 2024.

SRPT : 109.46 (-0.32%)
Sarepta Therapeutics: Q3 Earnings Snapshot

Sarepta Therapeutics: Q3 Earnings Snapshot

SRPT : 109.46 (-0.32%)
2 High-Flying Growth Stocks With Massive Upside Potential

These innovative drugmakers have potential catalysts ahead.

SRPT : 109.46 (-0.32%)
LLY : 871.86 (-0.13%)
Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics

These two could become direct competitors relatively soon.

SRPT : 109.46 (-0.32%)
WVE : 10.80 (-1.01%)
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher

Capricor Therapeutics Inc. (NASDAQ: CAPR) is a biotechnology firm focused on developing cell and exosome-based treatments for rare diseases like iomyopathy

SRPT : 109.46 (-0.32%)
PEPG : 1.2100 (-0.82%)
CAPR : 15.55 (+3.32%)
Implied Volatility Surging for Sarepta Therapeutics (SRPT) Stock Options

Investors in Sarepta Therapeutics, Inc. SRPT need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 18, 2024 $80 Call had some of the highest implied...

SRPT : 109.46 (-0.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company that focuses on the discovery and development of RNA-based therapeutics targeting rare and infectious diseases. It concentrates on the development of exon-skipping drug candidates targeting Duchenne muscular dystrophy (DMD), a...

See More

Key Turning Points

3rd Resistance Point 112.83
2nd Resistance Point 111.47
1st Resistance Point 110.46
Last Price 109.46
1st Support Level 108.10
2nd Support Level 106.74
3rd Support Level 105.73

See More

52-Week High 173.25
Fibonacci 61.8% 146.09
Fibonacci 50% 137.70
Fibonacci 38.2% 129.31
Last Price 109.46
52-Week Low 102.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Increase Profitable Opportunities with Barchart's Technical Opinion